Ioannis Mantzaris, MD, Bronx, NY | Internist
Meet the Hematologic Malignancy Team
Ioannis Mantzaris, MD, Bronx, NY | Internist
PDF) Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity
Dr. Ioannis Mantzaris, MD | Bronx, NY | Healthgrades
Ioannis Mantzaris's research works | Montefiore Medical Center, NY and other places
Novel Drug Shows Promise Against Acute Myeloid Leukemia | Albert Einstein College of Medicine
IL1RAP potentiates multiple oncogenic signaling pathways in AML. - Abstract - Europe PMC
Dr. Noah S. Kornblum, MD | Bronx, NY | Oncologist | US News Doctors
Ioannis Mantzaris, MD: Bronx, NY
2 "Ioannis Mantzaris" profiles | LinkedIn
Ioannis Mantzaris, MD, Bronx, NY | Internist
Ioannis Mantzaris, MD: Bronx, NY
Meet the Hematologic Malignancy Team
Progressive Multifocal Leukoencephalopathy Associated with Hematopoietic Stem Cell Transplant (HSCT) Has Better Prognosis Than PML Associated with Monoclonal Antibodies or Chemotherapy in Hematological Malignancies : Analysis of a Case Series – topic
Ioannis Mantzaris - Commercial Director - Quartic Training Ltd | LinkedIn
Ioannis Mantzaris - Commercial Director - Quartic Training Ltd | LinkedIn
Dr. John F. Reinus, MD | Bronx, NY | Gastroenterologist | US News Doctors
Dr. Ioannis Mantzaris, MD | Bronx, NY | Healthgrades
Equal Access to Hematopoietic Stem Cell Transplant in a Minority-Rich, Ethnically Diverse, Socioeconomically Disadvantaged Population with Peripheral T-Cell Lymphomas at the Montefiore Medical Center/Albert Einstein College of Medicine - ScienceDirect
Meet the Hematologic Malignancy Team
Iris Isufi, MD Hematology of Yale New Haven Hospital
Ioannis MANTZARIS | Fellowship | Albert Einstein College of Medicine, NY | AECOM | Albert Einstein Cancer Center - Page 2
Ioannis Mantzaris - Commercial Director - Quartic Training Ltd | LinkedIn
Ioannis Mantzaris, MD: Bronx, NY
Baseline Characteristics and Types of Cancer Therapy | Download Scientific Diagram
